New trivalent vaccine for clade 1 sarbecoviruses
The vaccine provided complete protection with no detectable virus in the lungs and could be a routine part of people’s medical treatment.
List view / Grid view
The vaccine provided complete protection with no detectable virus in the lungs and could be a routine part of people’s medical treatment.
Scientists have discovered the motor protein dynein commands movement of cancer cells in soft tissue models, offering new clinical targets.
A new single-cell nanoparticle targeting-sequencing approach can measure the cellular uptake of lipid nanoparticles carrying mRNA therapies.
Scientists have developed a novel type 1 diabetes treatment that involves transplanting pancreas cells that produce insulin.
Researchers have developed a new way to generate breast tumour models faster, more reliably and with less immune variability than existing models.
The new study looked at the network of gene-gene interactions associated with cancer onset and progression to identify therapeutic targets.
Scientists develop organoid models of neuroendocrine prostate cancer to study EZH2 inhibitors and reveal a potential new target.
27 May 2016 | By Victoria White, Digital Content Producer
By increasing the level of miR-374b, researchers have restored chemotherapy sensitivity to pancreatic cancer cells that had developed resistance...